Bundamedik Tbk (Indonesia) Performance
| BMHS Stock | 254.00 6.00 2.31% |
The firm shows a Beta (market volatility) of -0.2, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Bundamedik Tbk are expected to decrease at a much lower rate. During the bear market, Bundamedik Tbk is likely to outperform the market. At this point, Bundamedik Tbk PT has a negative expected return of -0.15%. Please make sure to confirm Bundamedik Tbk's total risk alpha, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to decide if Bundamedik Tbk PT performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Bundamedik Tbk PT has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's forward-looking signals remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors. ...more
| Total Cashflows From Investing Activities | -249.6 B |
Bundamedik |
Bundamedik Tbk Relative Risk vs. Return Landscape
If you would invest 28,600 in Bundamedik Tbk PT on November 2, 2024 and sell it today you would lose (3,200) from holding Bundamedik Tbk PT or give up 11.19% of portfolio value over 90 days. Bundamedik Tbk PT is generating negative expected returns and assumes 3.6294% volatility on return distribution over the 90 days horizon. Simply put, 32% of stocks are less volatile than Bundamedik, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Bundamedik Tbk Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bundamedik Tbk's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bundamedik Tbk PT, and traders can use it to determine the average amount a Bundamedik Tbk's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0407
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BMHS |
Estimated Market Risk
| 3.63 actual daily | 32 68% of assets are more volatile |
Expected Return
| -0.15 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bundamedik Tbk is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bundamedik Tbk by adding Bundamedik Tbk to a well-diversified portfolio.
Bundamedik Tbk Fundamentals Growth
Bundamedik Stock prices reflect investors' perceptions of the future prospects and financial health of Bundamedik Tbk, and Bundamedik Tbk fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bundamedik Stock performance.
| Return On Equity | 0.0811 | |||
| Return On Asset | 0.0465 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 3.68 T | |||
| Shares Outstanding | 8.6 B | |||
| Price To Book | 2.14 X | |||
| Price To Sales | 2.17 X | |||
| Revenue | 1.71 T | |||
| EBITDA | 291.45 B | |||
| Total Debt | 225.96 B | |||
| Book Value Per Share | 186.41 X | |||
| Cash Flow From Operations | 260.04 B | |||
| Earnings Per Share | 30.71 X | |||
| Total Asset | 2.69 T | |||
About Bundamedik Tbk Performance
By examining Bundamedik Tbk's fundamental ratios, stakeholders can obtain critical insights into Bundamedik Tbk's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Bundamedik Tbk is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Things to note about Bundamedik Tbk PT performance evaluation
Checking the ongoing alerts about Bundamedik Tbk for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bundamedik Tbk PT help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bundamedik Tbk PT generated a negative expected return over the last 90 days | |
| Bundamedik Tbk PT has high historical volatility and very poor performance | |
| About 79.0% of the company shares are held by company insiders |
- Analyzing Bundamedik Tbk's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bundamedik Tbk's stock is overvalued or undervalued compared to its peers.
- Examining Bundamedik Tbk's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bundamedik Tbk's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bundamedik Tbk's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bundamedik Tbk's stock. These opinions can provide insight into Bundamedik Tbk's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Bundamedik Stock
Bundamedik Tbk financial ratios help investors to determine whether Bundamedik Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bundamedik with respect to the benefits of owning Bundamedik Tbk security.